ADMA Biologics Inc vs Hut 8 Corp — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Hut 8 Corp trades at $93.25 (market cap $10.94B). The key difference: Hut 8 Corp is far larger — about 4.9× ADMA Biologics Inc's market cap, and Hut 8 Corp is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | HUT | |
|---|---|---|
Market Cap | $2.22B | $10.94B |
Sector | Health | Technology |
52-Week High | $20.38 | $133.02 |
52-Week Low | $7.60 | $21.37 |
Enterprise Value | $2.29B | $18.38B |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Hut 8 is one of North America's largest digital asset miners and infrastructure providers. It operates diversified data centers supporting Bitcoin mining and high-performance computing (HPC) for AI.
Read more on HUT →